Spironolactone Effect in Hepatic Ischemia/Reperfusion Injury in Wistar Rats

Spironolactone Effect in Hepatic Ischemia/Reperfusion Injury in Wistar Rats

Introduction. Ischemia/reperfusion (IR) injury, often associated with liver surgery, is an unresolved problem in the clinical practice. Spironolactone is an antagonist of aldosterone that has shown benefits over IR injury in several tissues, but its effects in hepatic IR are unknown. Objective. To e...

Full description

Bibliographic Details
Main Authors:	Julio César Jiménez Pérez, Araní Casillas Ramírez, Liliana Torres González, Linda Elsa Muñoz Espinosa, Marlene Marisol Perales Quintana, Gabriela Alarcón Galván, Homero Zapata Chavira, Francisco Javier Guzmán de la Garza, Carlos Rodrigo Cámara Lemarroy, Nancy Esthela Fernández Garza, Edelmiro Pérez Rodríguez, Paula Cordero Pérez
Format:	Article
Language:	English
Published:	Hindawi Limited 2016-01-01
Series:	Oxidative Medicine and Cellular Longevity
Online Access:	http://dx.doi.org/10.1155/2016/3196431

Similar Items

Nephroprotective Effect of Sonchus oleraceus Extract against Kidney Injury Induced by Ischemia-Reperfusion in Wistar Rats
by: Liliana Torres-González, et al.
Published: (2018-01-01)

Anti-inflammatory and antioxidant activity of essential amino acid α-ketoacid analogues against renal ischemia–reperfusion damage in Wistar rats
by: Concepción Sánchez-Martínez, et al.
Published: (2020-06-01)

Anti-inflammatory and nephroprotective activity of Juglans mollis against renal ischemia–reperfusion damage in a Wistar rat model
by: Jonathan Perez-Meseguer, et al.
Published: (2019-07-01)

Comparative Effects of Triflusal, S-Adenosylmethionine, and Dextromethorphan over Intestinal Ischemia/Reperfusion Injury
by: Carlos R. Cámara-Lemarroy, et al.
Published: (2011-01-01)

Evaluation of cyclooxigenase inhibitors in hepatic isquemia-reperfusion injury in Wistar rats
by: A.G. Garza, et al.
Published: (2020-09-01)

Temporal relationship of serum markers and tissue damage during acute intestinal ischemia/reperfusion
by: Francisco Javier Guzmán-de la Garza, et al.
Published: (2013-07-01)

Hepatoprotective effect of sodium (S)-2-hydroxyglutarate against ischemia-reperfusion injury in Wistar rats
by: E. Cienfuegos-Pecina, et al.
Published: (2020-09-01)

Metabolomic and biochemical characterization of a new model of the transition of acute kidney injury to chronic kidney disease induced by folic acid
by: Marlene Marisol Perales-Quintana, et al.
Published: (2019-06-01)

Novel role of spironolactone in the therapy of resistant hypertension: Spironolactone and resistant hypertension
by: Dragojević-Simić Viktorija, et al.
Published: (2019-01-01)

Arachidonic Acid Derivatives and Their Role in Peripheral Nerve Degeneration and Regeneration
by: Carlos Rodrigo Camara-Lemarroy, et al.
Published: (2012-01-01)

Effect of sodium (S)-2-hydroxyglutarate in male, and succinic acid in female Wistar rats against renal ischemia-reperfusion injury, suggesting a role of the HIF-1 pathway
by: Eduardo Cienfuegos-Pecina, et al.
Published: (2020-07-01)

Nuevos escenarios en el mercado de trabajo en México, 1983-1998
by: Esthela Gutiérrez Garza
Published: (1999-01-01)

Impacto del Tratado de Libre Comercio de América del Norte en las relaciones de trabajo en México
by: Esthela Gutiérrez Garza
Published: (2005-01-01)

DRESS syndrome secondary to spironolactone with atypical presentation
by: Anupama Bains, et al.
Published: (2020-01-01)

Spironolactone-Induced Agranulocytosis: A Case Report
by: Shu-Hwa Hsiao, et al.
Published: (2003-11-01)

Interactions Between Aldosterone, Spironolactone and the Cardiotonic Steroids
by: Shidyak, Amjad
Published: (2008)

Spironolactone use is associated with lower risk of prostate cancer
by: K. Beckmann, et al.
Published: (2020-07-01)

Furosemide and spironolactone doses and hyponatremia in patients with heart failure
by: Ivan Velat, et al.
Published: (2020-08-01)

Spironolactone-induced hypersensitivity in a patient with acne vulgaris
by: Bipin Mehta, et al.
Published: (2016-01-01)

Improving the dissolution properties of spironolactone using liquisolid technique
by: Jafar Akbari, et al.
Published: (2015-09-01)

Spironolactone Ameliorates Cochlear Implant Induced Endolymphatic Hydrops
by: Bester, C.W, et al.
Published: (2022)

Spironolactone in chronic hemodialysis patients improves cardiac function
by: Taheri Shahram, et al.
Published: (2009-01-01)

Effects of Spironolactone on Proteinuria of Patients with Type 2 Diabetes
by: Mohamad Karami Horestani, et al.
Published: (2012-10-01)

Crystal properties of drugs and solvent-deposition : Studies on spironolactone
by: Al-Sarraj, F. A.
Published: (1983)

Clinical efficacy of a benazepril and spironolactone combination in dogs with congestive heart failure due to myxomatous mitral valve disease: The BEnazepril Spironolactone STudy (BESST)
by: Melissa Coffman, et al.
Published: (2021-07-01)

Mechanisms involved in the beneficial effects of spironolactone after myocardial infarction.
by: Marcos F Minicucci, et al.
Published: (2013-01-01)

Spironolactone is effective in treating hypokalemia among peritoneal dialysis patients.
by: Amit Langote, et al.
Published: (2017-01-01)

Spironolactone and XPB: An Old Drug with a New Molecular Target
by: Ryan D. Gabbard, et al.
Published: (2020-05-01)

EFFECT OF SPIRONOLACTONE ON HEART RATE VARIABILITY (HRV) IN DIABETIC PATIENTS
by: Ramin Heydari, et al.
Published: (2010-12-01)

Spironolactone as an Adjunctive Treatment in Neovascular Age-Related Macular Degeneration
by: Kapil G. Kapoor, et al.
Published: (2017-05-01)

Studies of cyclodextrin complexes for drug delivery - spironolactone : cyclodextrin systems
by: Yusuff, Nahimot Titilayo
Published: (1990)

Outcomes of Spironolactone Withdrawal in Dilated Cardiomyopathy With Improved Ejection Fraction
by: Yanjia Chen, et al.
Published: (2021-09-01)

Role of spironolactone in patients with resistant hypertension: A narrative review
by: Geeta Sheth, et al.
Published: (2021-01-01)

ALDOSTERONE ANTAGONISTS. MODERN VIEWS ON THE MECHANISM OF ACTION AND EFFECTS OF SPIRONOLACTONE
by: V. I. Podzolkov, et al.
Published: (2017-05-01)

Efficacy of Spironolactone Treatment in Murine Models of Cutaneous and Visceral Leishmaniasis
by: Valter Viana Andrade-Neto, et al.
Published: (2021-04-01)

Modification of ventriculo–arterial coupling by spironolactone in nonischemic dilated cardiomyopathy
by: Mark A. Lawson, et al.
Published: (2021-04-01)

Hepatoprotective effect of nifedipine against ischemia-reperfusion injury in rats
by: A. Villarreal-Benítez, et al.
Published: (2020-09-01)

Compatibility determination of potassium orotate with spironolactone by high-performance liquid chromatography
by: Ecaterina Mazur, et al.
Published: (2020-10-01)

Spironolactone in pulmonary arterial hypertension: results of a cross-over study
by: Zeenat Safdar, et al.
Published: (2020-04-01)

Anti-inflammatory Effect of Spironolactone on Human Peripheral Blood Mononuclear Cells
by: Miura Ryuzea, et al.
Published: (2006-01-01)